share_log

HC Wainwright & Co. Reiterates Buy on Anixa Biosciences, Maintains $12 Price Target

HC Wainwright & Co. Reiterates Buy on Anixa Biosciences, Maintains $12 Price Target

HC Wainwright & Co.重申買入Anixa Biosciences,維持12美元的目標股價
Benzinga ·  2023/07/12 06:07

HC Wainwright & Co. analyst Yi Chen reiterates Anixa Biosciences (NASDAQ:ANIX) with a Buy and maintains $12 price target.

HC Wainwright&Co.分析師陳毅重申安妮莎生物科技(納斯達克:ANIX)買入,並維持12美元的目標價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論